James D Pipkin
Overview
Explore the profile of James D Pipkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zagami R, Franco D, Pipkin J, Antle V, De Plano L, Patane S, et al.
Int J Pharm
. 2020 Jun;
585:119487.
PMID: 32492506
Nowadays, novel less-expensive nanoformulations for in situ-controlled and safe delivery of photosensitisers (PSs) against opportunistic pathogens in body-infections areas need to be developed. Antimicrobial photodynamic therapy (aPDT) is a promising...
2.
Pettus J, DAlessio D, Frias J, Vajda E, Pipkin J, Rosenstock J, et al.
Diabetes Care
. 2019 Nov;
43(1):161-168.
PMID: 31694861
Objective: Evaluate the safety and efficacy of RVT-1502, a novel oral glucagon receptor antagonist, in subjects with type 2 diabetes inadequately controlled on metformin. Research Design And Methods: In a...
3.
Anraku M, Hiraga A, Iohara D, Pipkin J, Uekama K, Hirayama F
Int J Pharm
. 2015 Apr;
487(1-2):142-7.
PMID: 25882010
An intermolecular complex formed from a 1:1 weight ratio of chitosan (CS, molecular weight 30 kDa) and sulfobutyl ether β-cyclodextrin (SBE-β-CyD, degree of substitution 7) was less soluble than either...
4.
Uehata K, Anno T, Hayashida K, Motoyama K, Higashi T, Hirayama F, et al.
J Drug Deliv
. 2011 Dec;
2011:195146.
PMID: 22187651
Insulin glargine is a synthetic long-acting insulin product used for patients with diabetes mellitus. In this study, to obtain the further desirable blood-glucose lowering profile of insulin glargine, we investigated...
5.
Uehata K, Anno T, Hayashida K, Motoyama K, Hirayama F, Ono N, et al.
Int J Pharm
. 2011 Aug;
419(1-2):71-6.
PMID: 21803140
Insulin glargine is the first long-acting basal insulin analogue used for subcutaneous administration once daily in patients with type 1 or type 2 diabetes mellitus. To obtain the further bioavailability...
6.
Salapatek A, Lee J, Patel D, DAngelo P, Liu J, Zimmerer Jr R, et al.
Allergy Asthma Proc
. 2011 Apr;
32(3):221-9.
PMID: 21477425
Studies indicate that allergy sufferers remain dissatisfied with available antiallergic therapies. A new convenient formulation of solubilized steroid combined in the same nasal spray solution with antihistamine may provide added...